For context, the anti-TNF comparator cohort had a crude SAE rate of 13.3 per 1,000 patient-years (95% CI: 10.6–16.5) and a serious infection rate of 49.1 per 1,000 patient-years (95% CI: 43.8–54.8). The gene discussed is TNF; the disease is infection.